Clinical trials
Recruiting Carcinoma, Transitional Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 10 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mabwell (Shanghai) Bioscience Co., Ltd. | 3 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 3 |
| Peking University First Hospital | 2 |
| Pfizer | 2 |
| Abbisko Therapeutics Co, Ltd | 1 |
| AstraZeneca | 1 |
| Beijing Biotech | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 32 |
| Urinary Bladder Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Endometrial Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
| Carcinoma | 2 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Renal Cell | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.